Gedeon Richter's Cariprazine Publications Cover Two Decades of Research

Gedeon Richter Plc. has compiled an extensive list of scientific publications related to cariprazine, covering the period from 2006 to 2026. This collection offers a deep dive into the drug's research and development, encompassing its clinical and non-clinical applications.

The publications are categorized into several areas, including clinical studies focused on the treatment of schizophrenia, bipolar disorder, and major depression. The scientific review also features sections dedicated to cariprazine's pharmacokinetic properties and health technology assessments. Many of these publications are available through open access.

The compilation includes research from various time points, demonstrating sustained interest and efforts to understand and optimize cariprazine's use. Recent studies, published in 2026, address topics such as improving quality of life for patients with schizophrenia and managing negative symptoms.

This collection of publications serves as a resource for researchers, clinicians, and other healthcare professionals interested in the scientific background and clinical application of cariprazine. The company continues its commitment to advancing mental health treatments through ongoing research.